Related Experiment Video

Updated: May 23, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
08:57

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

IRF5 promotes the proliferation of human thyroid cancer cells

Michele Massimino1, Paolo Vigneri, Manuela Fallica

  • 1Department of Clinical and Molecular Bio-Medicine, University of Catania, Via Androne, 83-95124 Catania, Italy.

Molecular Cancer
|April 18, 2012
PubMed
Abstract

Insights

Interferon Regulatory Factor 5 (IRF5) unexpectedly promotes thyroid cancer growth and proliferation, contrary to its known tumor-suppressing roles in other cancers. This study reveals IRF5’s pro-tumorigenic function in thyroid malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Interferon Regulatory Factor 5 (IRF5) is a transcription factor involved in antiviral responses and immune stimulation.
  • IRF5 is recognized for its tumor-suppressive functions, inhibiting cell growth and oncogenesis.
  • Thyroid carcinoma incidence is increasing globally, necessitating research into its underlying molecular mechanisms.

Purpose of the Study:

  • To investigate the expression, localization, and functional role of IRF5 in thyroid cancer.
  • To determine if IRF5 acts as a tumor suppressor or promoter in thyroid malignancies.

Main Methods:

  • Analysis of IRF5 expression and localization in thyroid cancer cells and normal thyrocytes.
  • Modulation of IRF5 levels via Interferon alpha treatment and IRF5 silencing.
  • Assessment of cell proliferation, clonogenic potential, and response to DNA-damaging agents.

Main Results:

  • IRF5 is highly expressed in thyroid carcinomas but not in normal thyrocytes.
  • Ectopic IRF5 enhanced proliferation and clonogenic potential of thyroid cancer cells.
  • IRF5 silencing reduced colony-forming ability, and IRF5 induced B-Raf expression.

Conclusions:

  • IRF5 exhibits tumor-promoting activities in thyroid malignancies, contrasting its established tumor-suppressor role.
  • The cytoplasmic localization of IRF5 in thyroid cancer cells may explain its divergent function.
  • These findings highlight IRF5 as a potential therapeutic target in thyroid cancer.

More Related Videos

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...